| Literature DB >> 32115133 |
Kenneth A Katz1, Andrew J Park2, Julia L Marcus3.
Abstract
HIV remains an important public health concern in the United States, particularly for men who have sex with men (MSM) and transgender persons. With HIV preexposure prophylaxis (PrEP), persons who are HIV-uninfected take antiretroviral medications to prevent HIV infection. The most common PrEP regimen involves taking a single pill daily and is very effective in reducing risk of HIV infection, with few adverse effects. Barriers to PrEP access exist for MSM and transgender persons. Dermatologists can help combat the ongoing HIV epidemic among MSM, transgender persons, and others by understanding why, when, and how PrEP should be considered as an HIV prevention approach.Entities:
Keywords: HIV; Men who have sex with men; PrEP; Prevention; Transgender
Mesh:
Substances:
Year: 2019 PMID: 32115133 PMCID: PMC7183314 DOI: 10.1016/j.det.2019.10.008
Source DB: PubMed Journal: Dermatol Clin ISSN: 0733-8635 Impact factor: 3.478